China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Aponermin combined with KPd regimen in the treatment of patients with relapsed and refractory multiple myeloma: a multicenter, open-label, exploratory clinical study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136696

Registration Time: 2026/11/13

Type: Interventional study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=352310

Published by HT Digital Content Services with permission from Health Daily Digest....